Ksenya Shliakhtsitsava1, Erin Stucky Fisher2, Erin M Trovillion1, Kelly Bush1,3, Dennis John Kuo1, Ron S Newfield4, Courtney D Thornburg1, William Roberts1,3, Paula Aristizabal1,3,5. 1. Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of California, San Diego/Rady Children's Hospital San Diego, San Diego, California, USA. 2. Department of Pediatrics, Division of Pediatric Hospital Medicine, University of California, San Diego/Rady Children's Hospital San Diego, San Diego, California, USA. 3. Quality Improvement Committee, Division of Pediatric Hematology/Oncology, Rady Children's Hospital San Diego, San Diego, California, USA. 4. Department of Pediatrics, Division of Pediatric Endocrinology, University of California San Diego/Rady Children's Hospital San Diego, San Diego, California, USA. 5. Population Sciences, Disparities and Community Engagement, University of California San Diego Moores Cancer Center, La Jolla, California, USA.
Abstract
BACKGROUND: Vitamin D deficiency and insufficiency have been associated with poorer health outcomes. Children with cancer are at high risk for vitamin D deficiency and insufficiency. At our institution, we identified high variability in vitamin D testing and supplementation in this population. Of those tested, 65% were vitamin D deficient/insufficient. We conducted a quality improvement (QI) initiative with aim to improve vitamin D testing and supplementation among children aged 2-18 years with newly diagnosed cancer to ≥80% over 6 months. METHODS: An inter-professional team reviewed baseline data, then developed and implemented interventions using Plan-Do-Study-Act (PDSA) cycles. Barriers were identified using QI tools, including lack of automated triggers for testing and inconsistent supplementation criteria and follow-up testing post supplementation. Interventions included an institutional vitamin D guideline, clinical decision-making tree for vitamin D deficiency, insufficiency and sufficiency, electronic medical record triggers, and automated testing options. RESULTS: Baseline: N = 26 patients, four (15%) had baseline vitamin D testing; two (8%) received appropriate supplementation. Postintervention: N = 33 patients; 32 (97%) had baseline vitamin D testing; 33 (100%) received appropriate supplementation and completed follow-up testing timely (6-8 weeks post supplementation). Change was sustained over 24 months. CONCLUSIONS: We achieved and sustained our aim for vitamin D testing and supplementation in children with newly diagnosed cancer through inter-professional collaboration of hematology/oncology, endocrinology, hospital medicine, pharmacy, nursing, and information technology. Future PDSA cycles will address patient compliance with vitamin D supplementation and impact on patients' vitamin D levels.
BACKGROUND: Vitamin D deficiency and insufficiency have been associated with poorer health outcomes. Children with cancer are at high risk for vitamin D deficiency and insufficiency. At our institution, we identified high variability in vitamin D testing and supplementation in this population. Of those tested, 65% were vitamin D deficient/insufficient. We conducted a quality improvement (QI) initiative with aim to improve vitamin D testing and supplementation among children aged 2-18 years with newly diagnosed cancer to ≥80% over 6 months. METHODS: An inter-professional team reviewed baseline data, then developed and implemented interventions using Plan-Do-Study-Act (PDSA) cycles. Barriers were identified using QI tools, including lack of automated triggers for testing and inconsistent supplementation criteria and follow-up testing post supplementation. Interventions included an institutional vitamin D guideline, clinical decision-making tree for vitamin D deficiency, insufficiency and sufficiency, electronic medical record triggers, and automated testing options. RESULTS: Baseline: N = 26 patients, four (15%) had baseline vitamin D testing; two (8%) received appropriate supplementation. Postintervention: N = 33 patients; 32 (97%) had baseline vitamin D testing; 33 (100%) received appropriate supplementation and completed follow-up testing timely (6-8 weeks post supplementation). Change was sustained over 24 months. CONCLUSIONS: We achieved and sustained our aim for vitamin D testing and supplementation in children with newly diagnosed cancer through inter-professional collaboration of hematology/oncology, endocrinology, hospital medicine, pharmacy, nursing, and information technology. Future PDSA cycles will address patient compliance with vitamin D supplementation and impact on patients' vitamin D levels.
Authors: Elizabeth A Cummings; Jinhui Ma; Conrad V Fernandez; Jacqueline Halton; Nathalie Alos; Paivi M Miettunen; Jacob L Jaremko; Josephine Ho; Nazih Shenouda; Mary Ann Matzinger; Brian Lentle; David Stephure; Robert Stein; Ann Marie Sbrocchi; Celia Rodd; Bianca Lang; Sara Israels; Ronald M Grant; Robert Couch; Ronald Barr; John Hay; Frank Rauch; Kerry Siminoski; Leanne M Ward Journal: J Clin Endocrinol Metab Date: 2015-07-14 Impact factor: 5.958
Authors: O Mäkitie; R Heikkinen; S Toiviainen-Salo; M Henriksson; L-R Puukko-Viertomies; K Jahnukainen Journal: Eur J Endocrinol Date: 2013-01-17 Impact factor: 6.664
Authors: G Marcucci; G Beltrami; A Tamburini; J J Body; C B Confavreux; P Hadji; G Holzer; D Kendler; N Napoli; D D Pierroz; R Rizzoli; M L Brandi Journal: Ann Oncol Date: 2019-06-01 Impact factor: 32.976
Authors: Paula Aristizabal; Michael Sherer; Bianca P Perdomo; Esteban Castelao; Courtney D Thornburg; James Proudfoot; Elizabeth Jacobs; Ron S Newfield; Peter Zage; William Roberts; Maria Elena Martinez Journal: Pediatr Hematol Oncol Date: 2020-03-10 Impact factor: 1.969
Authors: Jacqueline Halton; Isabelle Gaboury; Ronald Grant; Nathalie Alos; Elizabeth A Cummings; Maryann Matzinger; Nazih Shenouda; Brian Lentle; Sharon Abish; Stephanie Atkinson; Elizabeth Cairney; David Dix; Sara Israels; David Stephure; Beverly Wilson; John Hay; David Moher; Frank Rauch; Kerry Siminoski; Leanne M Ward Journal: J Bone Miner Res Date: 2009-07 Impact factor: 6.741
Authors: A Catharine Ross; JoAnn E Manson; Steven A Abrams; John F Aloia; Patsy M Brannon; Steven K Clinton; Ramon A Durazo-Arvizu; J Christopher Gallagher; Richard L Gallo; Glenville Jones; Christopher S Kovacs; Susan T Mayne; Clifford J Rosen; Sue A Shapses Journal: J Clin Endocrinol Metab Date: 2010-11-29 Impact factor: 5.958
Authors: Sylvia Christakos; Martin Hewison; David G Gardner; Carol L Wagner; Igor N Sergeev; Erica Rutten; Anastassios G Pittas; Ricardo Boland; Luigi Ferrucci; Daniel D Bikle Journal: Ann N Y Acad Sci Date: 2013-05-17 Impact factor: 5.691
Authors: Alicia K Heath; Iris Y Kim; Allison M Hodge; Dallas R English; David C Muller Journal: Int J Environ Res Public Health Date: 2019-01-29 Impact factor: 3.390